Fonar posts turnaround in FY2009

Fonar has reported a profit of $1.1 million for the 2009 fiscal year ending June 30, a striking improvement over its fiscal 2008 performance in which the company posted a net loss of $13.5 million.

After fighting off acquisitions and threatened NASDAQ delisting in 2008, the company said its total revenues increased by 12 percent to $39.7 million in fiscal 2009, up from $35.6 million reported in fiscal 2008. Operating costs and expenses declined by 23 percent, from $52.5 million in 2008 to $40.4 in 2009.

Raymond Damadian, chairman and president of the Melville, N.Y.-based company, credited the performance of its Upright Multi-Position MRI scanners with helping to bring the company back to profitability. According to the firm, product sales of the scanners increased 48 percent from $11.2 million in fiscal 2008 to $16.6 million in 2009.
Michael Bassett,

Contributor

Around the web

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Trimed Popup
Trimed Popup